Benzinga's Top #PreMarket Gainers - bluebird bio (NASDAQ:BLUE), Anavex Life Sciences (NASDAQ:AVXL)

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.

Anavex Life Sciences Corp. (NASDAQ: AVXL) shares climbed 23.46 percent to $4.00 in pre-market trading after the company announced that it is moving forward with the development program for ANAVEX 2-7.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Fairchild Semiconductor Intl Inc (NASDAQ: FCS) shares surged 8.11 percent to $19.33 in pre-market trading following announcement of ON Semiconductor Corp (NASDAQ: ON) $20.00 per share offer.

Buy at this blue line for a shot at trading profitably

There are so many indicators out there on when to buy and sell. Nic uses none. He looks at a chart and buys when a stock “pushes” off this blue line. What blue line? Find out on the next page. It’ll change how you make money from stocks. Click here for the details.

Norfolk Southern Corp. (NYSE: NSC) shares rose 5.78 percent to $92.00 in pre-market trading following

Canadian Pacific Railway Limited (USA) (NYSE: CP) announcement of details of offer. bluebird bio Inc (NASDAQ: BLUE) gained 5.14 percent to $83.70 in pre-market trading. Goldman Sachs initiated coverage on bluebird bio with a Buy rating and a $165.00 price target. Lowe's Companies, Inc. (NYSE: LOW) shares rose 2.25 percent to $74.49 in pre-market trading after the company reported stronger-than-expected results for the third quarter.